Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in Children With Portal Hypertension
NCT05767229Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carvedilol in Portal Hypertension (PH), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Proportion of children with acute hemodynamic response at 90 minutes. Started Mar 2023; status: completed.
02
Drugs
carvedilol
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT05767229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05767229.